Court Won't Stay Generic Approval Of HDI Body Oil

Law360, New York (December 3, 2007, 12:00 AM EST) -- Dermatological products manufacturer Hill Dermaceuticals Inc. has come up short in its bid for a stay to prevent the U.S. Food & Drug Administration from approving any generic version of its brand-name scalp and body oil until the agency fully responds to its citizen petition.

Judge Royce C. Lamberth of the U.S. District Court for the District of Columbia concluded on Thursday that the FDA complied with regulations by offering HDI a tentative response and denied HDI’s attempt to stop the FDA from passing through generic...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.